Literature DB >> 29893949

Effect of Social Support on Psychological Distress and Disease Activity in Inflammatory Bowel Disease Patients.

Vered Slonim-Nevo1, Orly Sarid1, Michael Friger2, Doron Schwartz3, Ruslan Sergienko2, Avihu Pereg4, Hillel Vardi2, Terri Singer4, Elena Chernin2, Dan Greenberg5, Shmuel Odes4.   

Abstract

Background: Psychological distress increases morbidity in ulcerative colitis (UC) and Crohn's disease (CD). We examined whether social support is associated with distress and disease activity.
Methods: There were 110 UC and 147 CD patients who completed sociodemography, economic status, disease activity (UC: Patient Simple Clinical Colitis Activity Index (P-SCCAI), CD: Patient Harvey-Bradshaw Index . (P-HBI), Multidimensional Scale of Perceived Social Support (MSPSS), Brief Symptom Inventory with Global Severity Index (GSI) of psychological distress, and 2 health-related quality-of-life scales (SF-36 Physical Health and Mental Health, and Short Inflammatory Bowel Disease Questionnaire (SIBDQ). Analysis included multiple linear regressions and structural equation modeling.
Results: Disease activity was mild: UC: P-SCCAI 2.9 ± 3.5, CD: P-HBI 4.7 ± 4.7. Physical Health was better in UC 46.6 ± 11.4 versus CD 43.7 ± 10.9 (P < .02). GSI was lower in UC 0.6 ± 0.7 than CD 0.8 ± 0.7 (P = .002). MSPSS total score was equal in UC (5.9 ± 1.2) and CD (5.9 ± 1.1). MSPSS total correlated with P-SCCAI (correlation coefficient ‒0.240), GSI in UC (‒0.470), and GSI in CD (‒0.333). Economic status correlated with GSI in UC (‒0.408) and CD (‒0.356). MSPSS predicted GSI, Mental Health, and SIBDQ in UC and CD, and predicted P-SCCAI but not P-HBI; economic status predicted all the foregoing. Path analysis depicted GSI as mediating the effects of MSPSS and economic status on disease activity in both UC and CD. MSPSS (UC: β ‒0.34, CD: β ‒0.37) and economic status (UC: β ‒0.38, CD: β ‒0.22) reduced GSI, which then increased the disease activity (UC: β 0.56, CD: β 0.42). Conclusions: Social support and economic status are linked to UC and CD patients' well-being. Interventions addressing these issues should be part of management.

Entities:  

Mesh:

Year:  2018        PMID: 29893949     DOI: 10.1093/ibd/izy041

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  6 in total

1.  A Novel Patient-Reported Outcome-Based Evaluation (PROBE) of Quality of Life in Patients With Inflammatory Bowel Disease.

Authors:  Edward L Barnes; Michael D Kappelman; Millie D Long; Donna M Evon; Christopher F Martin; Robert S Sandler
Journal:  Am J Gastroenterol       Date:  2019-04       Impact factor: 10.864

2.  Examining Psychosocial Mechanisms of Pain-Related Disability in Inflammatory Bowel Disease.

Authors:  Katherine M Fretz; Dean A Tripp; Laura Katz; Mark Ropeleski; Michael J Beyak
Journal:  J Clin Psychol Med Settings       Date:  2020-03

3.  Prevalence and Effects of Food Insecurity and Social Support on Financial Toxicity in and Healthcare Use by Patients With Inflammatory Bowel Diseases.

Authors:  Nghia H Nguyen; Rohan Khera; Lucila Ohno-Machado; William J Sandborn; Siddharth Singh
Journal:  Clin Gastroenterol Hepatol       Date:  2020-06-09       Impact factor: 13.576

4.  Questionnaire assessment helps the self-management of patients with inflammatory bowel disease during the outbreak of Coronavirus Disease 2019.

Authors:  Meiping Yu; Zhenghao Ye; Yu Chen; Tingting Qin; Jiguang Kou; De'an Tian; Fang Xiao
Journal:  Aging (Albany NY)       Date:  2020-07-03       Impact factor: 5.682

5.  A cross-sectional survey on the psychological impact of the COVID-19 pandemic on inflammatory bowel disease patients in Saudi Arabia.

Authors:  Mahmoud Mosli; Mansour Alourfi; Amani Alamoudi; Almoutaz Hashim; Omar Saadah; Eman Al Sulais; Turki AlAmeel; Othman Alharbi; Shakir Bakari; Yaser Meeralam; Seigha Alshobai; Majid Alsahafi; Hani Jawa; Yousif Qari
Journal:  Saudi J Gastroenterol       Date:  2020 Sep-Oct       Impact factor: 2.485

6.  Associations between inflammatory bowel disease, social isolation, and mortality: evidence from a longitudinal cohort study.

Authors:  Jie Chen; Jiawei Geng; Jiayi Wang; Zhenhua Wu; Tian Fu; Yuhao Sun; Xuejie Chen; Xiaoyan Wang; Therese Hesketh
Journal:  Therap Adv Gastroenterol       Date:  2022-09-30       Impact factor: 4.802

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.